Moderator's view: Biomarkers in glomerular diseases--translated into patient care or lost in translation?

Affiliations

¹ Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1155, Paris F-75005, France INSERM, UMR_S 1155, Batiment Recherche, Hôpital Tenon, 4 rue de la Chine, Paris F-75020, France Department of Nephrology and Dialysis, AP-HP, Hôpital Tenon, Paris F-75020, France.

Comment

Pierre Ronco. Nephrol Dial Transplant. 2015 Jun.

. 2015 Jun;30(6):899-902.

doi: 10.1093/ndt/gfv106.

¹ Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1155, Paris F-75005, France INSERM, UMR_S 1155, Batiment Recherche, Hôpital Tenon, 4 rue de la Chine, Paris F-75020, France Department of Nephrology and Dialysis, AP-HP, Hôpital Tenon, Paris F-75020, France.

No abstract available

Comment on

Con: Biomarkers in glomerular diseases: putting the cart before the wheel?
De Vriese AS, Fervenza FC. De Vriese AS, et al. Nephrol Dial Transplant. 2015 Jun;30(6):885-90. doi: 10.1093/ndt/gfv107. Nephrol Dial Transplant. 2015. PMID: 25994657
Pro: 'The usefulness of biomarkers in glomerular diseases'. The problem: moving from syndrome to mechanism--individual patient variability in disease presentation, course and response to therapy.
Mariani LH, Kretzler M. Mariani LH, et al. Nephrol Dial Transplant. 2015 Jun;30(6):892-8. doi: 10.1093/ndt/gfv108. Nephrol Dial Transplant. 2015. PMID: 25994659 Free PMC article. Review.